Hepatoma

Hepatoma is a type of cancer that develops in the liver. It is also known as hepatocellular carcinoma (HCC). This cancer is one of the most common primary malignant tumors of the liver and is the second leading cause of cancer-related death in the world. Hepatoma occurs when healthy liver cells become damaged and are replaced by abnormal cells that grow and divide rapidly. These damaged cells can accumulate into a mass that can be either benign or malignant. The exact cause of hepatoma is unknown; however, certain risk factors have been identified, such as long-term infection with the hepatitis B or C virus, cirrhosis, aflatoxins, alcohol abuse and exposure to certain chemicals. Symptoms of hepatoma may include abdominal pain, weight loss, jaundice, fatigue, and loss of appetite. Diagnosis usually involves imaging tests such as CT scans or MRI scans, as well as blood tests and biopsy. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and ablation. The prognosis depends on the stage of the cancer, the size of the tumor, and the patient's response to treatment.